{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:17:25Z","timestamp":1791274645538,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"47","license":[{"start":{"date-parts":[[2011,5,30]],"date-time":"2011-05-30T00:00:00Z","timestamp":1306713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,5,30]],"date-time":"2011-05-30T00:00:00Z","timestamp":1306713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2011,11,24]]},"DOI":"10.1038\/onc.2011.191","type":"journal-article","created":{"date-parts":[[2011,5,30]],"date-time":"2011-05-30T14:08:50Z","timestamp":1306764530000},"page":"4757-4764","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations"],"prefix":"10.1038","volume":"30","author":[{"given":"M A W","family":"Rowh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"DeMicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J E","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K S","family":"Yang-Iott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Fusello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Hobeika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Reth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C H","family":"Bassing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,30]]},"reference":[{"key":"BFonc2011191_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/318533a0","volume":"318","author":"JM Adams","year":"1985","unstructured":"Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S et al. (1985). The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318: 533\u2013538.","journal-title":"Nature"},{"key":"BFonc2011191_CR2","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1182\/blood-2007-08-104760","volume":"111","author":"CH Bassing","year":"2007","unstructured":"Bassing CH, Ranganath S, Murphy M, Savic V, Gleason M, Alt FW . (2007). Aberrant V(D)J recombination is not required for rapid development of H2ax\/p53 deficient thymic lymphomas with clonal translocations. Blood 111: 2163\u20132169.","journal-title":"Blood"},{"key":"BFonc2011191_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0092-8674(03)00566-X","volume":"114","author":"CH Bassing","year":"2003","unstructured":"Bassing CH, Suh H, Ferguson DO, Chua KF, Manis J, Eckersdorff M et al. (2003). Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114: 359\u2013370.","journal-title":"Cell"},{"key":"BFonc2011191_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0092-8674(03)00567-1","volume":"114","author":"A Celeste","year":"2003","unstructured":"Celeste A, Difilippantonio S, Difilippantonio MJ, Fernandez-Capetillo O, Pilch DR, Sedelnikova OA et al. (2003a). H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114: 371\u2013383.","journal-title":"Cell"},{"key":"BFonc2011191_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/ncb1004","volume":"5","author":"A Celeste","year":"2003","unstructured":"Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A et al. (2003b). Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol 5: 675\u2013679.","journal-title":"Nat Cell Biol"},{"key":"BFonc2011191_CR6","first-page":"6194","volume":"62","author":"AMY Cheung","year":"2002","unstructured":"Cheung AMY, Hande MP, Jalali F, Tsao M-S, Skinnider B, Hirao A et al. (2002). Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis. Cancer Res 62: 6194\u20136204.","journal-title":"Cancer Res"},{"key":"BFonc2011191_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1365-2141.2009.07739.x","volume":"146","author":"KJ Cheung","year":"2009","unstructured":"Cheung KJ, Horsman DE, Gascoyne RD . (2009). The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target. Br J Haematol 146: 257\u2013269.","journal-title":"Br J Haematol"},{"key":"BFonc2011191_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1084\/jem.20020851","volume":"196","author":"MJ Difilippantonio","year":"2002","unstructured":"Difilippantonio MJ, Petersen S, Chen HT, Johnson R, Jasin M, Kanaar R et al. (2002). Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J Exp Med 196: 469\u2013480.","journal-title":"J Exp Med"},{"key":"BFonc2011191_CR9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/35006670","volume":"404","author":"MJ Difilippantonio","year":"2000","unstructured":"Difilippantonio MJ, Zhu J, Chen HT, Meffre E, Nussenzweig MC, Max EE et al. (2000). DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404: 510\u2013514.","journal-title":"Nature"},{"key":"BFonc2011191_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/356215a0","volume":"356","author":"LA Donehower","year":"1992","unstructured":"Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS et al. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215\u2013221.","journal-title":"Nature"},{"key":"BFonc2011191_CR11","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/onc.2009.394","volume":"29","author":"ME Dujka","year":"2010","unstructured":"Dujka ME, Puebla-Osorio N, Tavana O, Sang M, Zhu C. . (2010). ATM and p53 are essential in the cell-cycle containment of DNA breaks during V(D)J recombination in vivo. Oncogene 29: 957\u2013965.","journal-title":"Oncogene"},{"key":"BFonc2011191_CR12","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1038\/onc.2010.163","volume":"29","author":"T Fishler","year":"2010","unstructured":"Fishler T, Li YY, Wang RH, Kim HS, Sengupta K, Vassilopoulos A et al. (2010). Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53. Oncogene 29: 4007\u20134017.","journal-title":"Oncogene"},{"key":"BFonc2011191_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/35009138","volume":"404","author":"Y Gao","year":"2000","unstructured":"Gao Y, Ferguson DO, Xie W, Manis JP, Sekiguchi J, Frank KM et al. (2000). Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404: 897\u2013900.","journal-title":"Nature"},{"key":"BFonc2011191_CR14","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0092-8674(00)81714-6","volume":"95","author":"Y Gao","year":"1998","unstructured":"Gao Y, Sun Y, Frank KM, Dikkes P, Fujiwara Y, Seidl KJ et al. (1998). A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95: 891\u2013902.","journal-title":"Cell"},{"key":"BFonc2011191_CR15","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1182\/blood-2008-07-165167","volume":"113","author":"W Giblin","year":"2009","unstructured":"Giblin W, Chatterji M, Westfield G, Masud T, Theisen B, Cheng H-L et al. (2009). Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation. Blood 113: 2965\u20132975.","journal-title":"Blood"},{"key":"BFonc2011191_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1535-6108(02)00236-2","volume":"3","author":"RA Gladdy","year":"2003","unstructured":"Gladdy RA, Taylor MD, Williams CJ, Grandal I, Karaskova J, Squire JA et al. (2003). The RAG-1\/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53\/Prkdc-deficient mice. Cancer Cell 3: 37\u201350.","journal-title":"Cancer Cell"},{"key":"BFonc2011191_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ccr.2006.01.004","volume":"9","author":"BB Haines","year":"2006","unstructured":"Haines BB, Ryu CJ, Chang S, Protopopov A, Luch A, Kang YH et al. (2006). Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations. Cancer Cell 9: 109\u2013120.","journal-title":"Cancer Cell"},{"key":"BFonc2011191_CR18","doi-asserted-by":"publisher","first-page":"13789","DOI":"10.1073\/pnas.0605944103","volume":"103","author":"E Hobeika","year":"2006","unstructured":"Hobeika E, Thiemann S, Storch B, Jumaa H, Nielsen PJ, Pelanda R et al. (2006). Testing gene function early in the B cell lineage in mb1-cre mice. Proc Natl Acad Sci USA 103: 13789\u201313794.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011191_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","volume":"4","author":"T Jacks","year":"1994","unstructured":"Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT et al. (1994). Tumor spectrum analysis in p53-mutant mice. Curr Biol 4: 1\u20137.","journal-title":"Curr Biol"},{"key":"BFonc2011191_CR20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/ng747","volume":"29","author":"J Jonkers","year":"2001","unstructured":"Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A . (2001). Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29: 418\u2013425.","journal-title":"Nat Genet"},{"key":"BFonc2011191_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc1589","volume":"5","author":"R Kuppers","year":"2005","unstructured":"Kuppers R. . (2005). Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 5: 251\u2013262.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2011191_CR22","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1128\/MCB.18.6.3495","volume":"18","author":"MJ Liao","year":"1998","unstructured":"Liao MJ, Zhang XX, Hill R, Gao J, Qumsiyeh MB, Nichols W et al. (1998). No requirement for V(D)J recombination in p53-deficient thymic lymphoma. Mol Cell Biol 18: 3495\u20133501.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011191_CR23","doi-asserted-by":"publisher","first-page":"9209","DOI":"10.1073\/pnas.161269798","volume":"98","author":"A Loonstra","year":"2001","unstructured":"Loonstra A, Vooijs M, Beverloo HB, Allak BA, van Drunen E, Kanaar R et al. (2001). Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA 98: 9209\u20139214.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011191_CR24","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1038\/sj.emboj.7600363","volume":"23","author":"D MacPherson","year":"2004","unstructured":"MacPherson D, Kim J, Kim T, Rhee BK, van Oostrom CThM, DiTullio Jr RA et al. (2004). Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23. EMBO J 23: 3689\u20133699.","journal-title":"EMBO J"},{"key":"BFonc2011191_CR25","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1038\/onc.2008.111","volume":"27","author":"RM Nepal","year":"2008","unstructured":"Nepal RM, Zaheen A, Basit W, Li L, Berger SA, Martin A . (2008). AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice. Oncogene 27: 4752\u20134756.","journal-title":"Oncogene"},{"key":"BFonc2011191_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature04495","volume":"440","author":"AR Ramiro","year":"2006","unstructured":"Ramiro AR, Jankovic M, Callen E, Difilippantonio S, Chen HT, McBride KM et al. (2006). Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440: 105\u2013109.","journal-title":"Nature"},{"key":"BFonc2011191_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ccr.2006.11.024","volume":"11","author":"HC Reinhardt","year":"2007","unstructured":"Reinhardt HC, Aslanian AS, Lees JA, Yaffe MB . (2007). p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK\/MK2 pathway for survival after DNA damage. Cancer Cell 11: 175\u2013189.","journal-title":"Cancer Cell"},{"key":"BFonc2011191_CR28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.molcel.2009.11.007","volume":"36","author":"DF Robbiani","year":"2009","unstructured":"Robbiani DF, Bunting S, Feldhahn N, Bothmer A, Camps J, Deroubaix S et al. (2009). AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol Cell 36: 631\u2013641.","journal-title":"Mol Cell"},{"key":"BFonc2011191_CR29","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1073\/pnas.0308757101","volume":"101","author":"S Rooney","year":"2004","unstructured":"Rooney S, Sekiguchi J, Whitlow S, Eckersdorff M, Manis JP, Lee C et al. (2004). Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. Proc Natl Acad Sci USA 101: 2410\u20132415.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011191_CR30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1084\/jem.20092308","volume":"207","author":"MA Santos","year":"2010","unstructured":"Santos MA, Huen MS, Jankovic M, Chen HT, Lopez-Contreras AJ, Klein IA et al. (2010). Class switching and meiotic defects in mice lacking the E3 ubiquitin ligase RNF8. J Exp Med 207: 973\u2013981.","journal-title":"J Exp Med"},{"key":"BFonc2011191_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1097-2765(01)00295-7","volume":"8","author":"DP Silver","year":"2001","unstructured":"Silver DP, Livingston DM . (2001). Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell 8: 233\u2013243.","journal-title":"Mol Cell"},{"key":"BFonc2011191_CR32","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/cdd.2009.136","volume":"17","author":"TL Slatter","year":"2009","unstructured":"Slatter TL, Ganesan P, Holzhauer C, Mehta R, Rubio C, Williams G et al. (2009). p53-mediated apoptosis prevents the accumulation of progenitor B cells and B-cell tumors. Cell Death Diff 17: 540\u2013550.","journal-title":"Cell Death Diff"},{"key":"BFonc2011191_CR33","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1038\/sj.onc.1208399","volume":"24","author":"DP Smith","year":"2005","unstructured":"Smith DP, Bath ML, Harris AW, Cory S . (2005). T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC. Oncogene 24: 3544\u20133553.","journal-title":"Oncogene"},{"key":"BFonc2011191_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"KH Vousden","year":"2009","unstructured":"Vousden KH, Prives C . (2009). Blinded by the Light: The growing complexity of p53. Cell 137: 413\u2013431.","journal-title":"Cell"},{"key":"BFonc2011191_CR35","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1084\/jem.20082271","volume":"205","author":"JH Wang","year":"2008","unstructured":"Wang JH, Alt FW, Gostissa M, Datta A, Murphy M, Alimzhanov MB et al. (2008). Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching. J Exp Med 205: 3079\u20133090.","journal-title":"J Exp Med"},{"key":"BFonc2011191_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature08159","volume":"460","author":"JH Wang","year":"2009","unstructured":"Wang JH, Gostissa M, Yan CT, Goff P, Hickernell T, Hansen E et al. (2009). Mechanisms promoting translocations in editing and switching peripheral B cells. Nature 460: 231\u2013236.","journal-title":"Nature"},{"key":"BFonc2011191_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1074-7613(02)00515-0","volume":"18","author":"C Wu","year":"2003","unstructured":"Wu C, Bassing CH, Jung D, Woodman BB, Foy D, Alt FW . (2003). Dramatically increased rearrangement and peripheral representation of Vbeta14 driven by the 3\u2032Dbeta1 recombination signal sequence. Immunity 18: 75\u201385.","journal-title":"Immunity"},{"key":"BFonc2011191_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1182\/blood-2010-03-273045","volume":"117","author":"B Yin","year":"2010","unstructured":"Yin B, Yang-Iott KS, Chao L, Bassing CH . (2010). Cellular context dependent effects of H2ax and p53 deletion upon the development of thymic lymphoma. Blood Oct 117: 175\u2013185. [Epub ahead of print].","journal-title":"Blood Oct"},{"key":"BFonc2011191_CR39","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0092-8674(02)00770-5","volume":"109","author":"C Zhu","year":"2002","unstructured":"Zhu C, Mills KD, Ferguson DO, Lee C, Manis J, Fleming J et al. (2002). Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 109: 811\u2013821.","journal-title":"Cell"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2011191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011191","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:22:30Z","timestamp":1647886950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2011191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,30]]},"references-count":39,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2011,11,24]]}},"alternative-id":["BFonc2011191"],"URL":"https:\/\/doi.org\/10.1038\/onc.2011.191","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,30]]},"assertion":[{"value":"27 August 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}